Nuclear structure in the development of lupus autoimmunity

狼疮自身免疫发展中的核结构

基本信息

  • 批准号:
    8449116
  • 负责人:
  • 金额:
    $ 7.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is regarded as a failure of adaptive immunity due to a loss of tolerance to nuclear self-antigens. In human SLE patients and mouse models, the presence of anti-nuclear antibodies is a diagnostic criterion for the disease. Despite significant advances in our understanding of the progression of SLE, including the critical role of type I interferons, less is known of the mechanisms that mediate the development of autoimmunity. Defects in the initiation, execution or resolution of apoptosis can induce the development of anti-nuclear antibodies. This suggests that proper handling of the nucleus during apoptosis is essential to avoid induction of an aberrant immune response. Nuclear fragmentation involves cleavage of both genomic DNA and structural components of the nuclear envelope. A nuclear envelope protein cleaved during apoptosis is the Lamin B Receptor (LBR). The LBR stabilizes nuclear structure by binding both chromatin and the nuclear lamina. LBR located within the SLEB1 lupus susceptibility interval on 1q42 in humans, and in the syntenic regions Sle1, Nba-2, Swrl-1 in mice. This proposal tests the role of disruption of LBR in the development of lupus autoimmunity by introducing a defective Lbr gene into established models of lupus, and by analyzing the expression of LBR in lupus-prone mouse strains.
描述(申请人提供):系统性红斑狼疮(SLE)被认为是由于失去对核自身抗原的耐受性而导致的获得性免疫失败。在人类SLE患者和小鼠模型中,抗核抗体的存在是疾病的诊断标准。尽管我们对系统性红斑狼疮的进展有了很大的了解,包括I型干扰素的关键作用,但对调节自身免疫发展的机制知之甚少。在启动、执行或解决细胞凋亡的过程中存在缺陷,可导致抗核抗体的产生。这表明,在细胞凋亡过程中,对细胞核的适当处理对于避免诱导异常免疫反应至关重要。核碎裂包括基因组DNA和核膜结构成分的裂解。在细胞凋亡过程中被切割的核膜蛋白是Lamin B受体(LBR)。LBR通过结合染色质和核层来稳定核结构。人LBR位于SLEB1狼疮易感区间,小鼠LBR位于Sle1、NBA-2、Swrl-1共线区。这项建议通过将LBR基因缺陷的LBR基因导入已建立的狼疮模型,并通过分析LBR在狼疮易感小鼠品系中的表达,来测试LBR的干扰在狼疮自身免疫发展中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael F Denny其他文献

Michael F Denny的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael F Denny', 18)}}的其他基金

Nuclear structure in the development of lupus autoimmunity
狼疮自身免疫发展中的核结构
  • 批准号:
    8099943
  • 财政年份:
    2011
  • 资助金额:
    $ 7.27万
  • 项目类别:
Nuclear structure in the development of lupus autoimmunity
狼疮自身免疫发展中的核结构
  • 批准号:
    8232047
  • 财政年份:
    2011
  • 资助金额:
    $ 7.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了